China’s Haisco forms immunology biotech with up to $1.5B from American VCs

By /

Haisco Pharmaceutical Group has been on a deal hot streak this year, inking major deals with Eli Lilly, AbbVie and more. The new company will take on one of Haisco’s core immunology assets.

Scroll to Top